Rafferty Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.2M | Sell |
193,053
-76,567
| -28% | -$8.84M | 0.09% | 115 |
|
|
2025
Q4 | $28.4M | Sell |
269,620
-10,228
| -4% | -$960K | 0.1% | 113 |
|
|
2025
Q3 | $23.5M | Buy |
279,848
+11,466
| +4% | +$944K | 0.08% | 137 |
|
|
2025
Q2 | $21.2M | Buy |
268,382
+30,670
| +13% | +$2.44M | 0.07% | 143 |
|
|
2025
Q1 | $21.3M | Sell |
237,712
-52,722
| -18% | -$4.92M | 0.09% | 131 |
|
|
2024
Q4 | $28.9M | Buy |
290,434
+29,554
| +11% | +$3.05M | 0.1% | 121 |
|
|
2024
Q3 | $29.6M | Sell |
260,880
-17,704
| -6% | -$2.1M | 0.1% | 113 |
|
|
2024
Q2 | $34.5M | Buy |
278,584
+12,966
| +5% | +$1.67M | 0.13% | 92 |
|
|
2024
Q1 | $35M | Buy |
265,618
+3,715
| +1% | +$458K | 0.13% | 87 |
|
|
2023
Q4 | $28.6M | Sell |
261,903
-6,258
| -2% | -$650K | 0.12% | 105 |
|
|
2023
Q3 | $27.6M | Buy |
268,161
+19,769
| +8% | +$2.13M | 0.16% | 82 |
|
|
2023
Q2 | $28.7M | Buy |
248,392
+19,079
| +8% | +$2.17M | 0.16% | 81 |
|
|
2023
Q1 | $24.4M | Buy |
229,313
+8,481
| +4% | +$916K | 0.17% | 86 |
|
|
2022
Q4 | $24.5M | Buy |
220,832
+82,454
| +60% | +$8.43M | 0.21% | 81 |
|
|
2022
Q3 | $11.9M | Buy |
138,378
+74,303
| +116% | +$6.63M | 0.13% | 126 |
|
|
2022
Q2 | $5.84M | Sell |
64,075
-18,716
| -23% | -$1.66M | 0.05% | 259 |
|
|
2022
Q1 | $6.79M | Sell |
82,791
-14,037
| -14% | -$1.11M | 0.04% | 279 |
|
|
2021
Q4 | $7.42M | Buy |
96,828
+5,685
| +6% | +$453K | 0.04% | 251 |
|
|
2021
Q3 | $6.85M | Buy |
91,143
+32,475
| +55% | +$2.47M | 0.05% | 238 |
|
|
2021
Q2 | $4.56M | Sell |
58,668
-376
| -0.6% | -$28K | 0.03% | 345 |
|
|
2021
Q1 | $4.34M | Buy |
59,044
+3,862
| +7% | +$285K | 0.03% | 314 |
|
|
2020
Q4 | $4.31M | Sell |
55,182
-2,137
| -4% | -$163K | 0.04% | 254 |
|
|
2020
Q3 | $4.54M | Sell |
57,319
-12,037
| -17% | -$943K | 0.05% | 195 |
|
|
2020
Q2 | $5.12M | Buy |
69,356
+42,166
| +155% | +$3.17M | 0.07% | 173 |
|
|
2020
Q1 | $2M | Sell |
27,190
-67,786
| -71% | -$5.33M | 0.08% | 147 |
|
|
2019
Q4 | $8.24M | Buy |
94,976
+61,763
| +186% | +$5.07M | 0.13% | 91 |
|
|
2019
Q3 | $2.67M | Sell |
33,213
-2,363
| -7% | -$189K | 0.04% | 254 |
|
|
2019
Q2 | $2.85M | Buy |
35,576
+28,976
| +439% | +$2.22M | 0.05% | 264 |
|
|
2019
Q1 | $524K | Buy |
+6,600
| New | +$494K | 0.01% | 665 |
|
|
2018
Q4 | – | Sell |
-3,095
| Closed | -$209K | – | 684 |
|
|
2018
Q3 | $209K | Buy |
+3,095
| New | +$197K | ﹤0.01% | 673 |
|
|
2017
Q2 | – | Sell |
-7,356
| Closed | -$446K | – | 580 |
|
|
2017
Q1 | $446K | Buy |
+7,356
| New | +$446K | 0.01% | 497 |
|
|
2015
Q3 | – | Sell |
-5,829
| Closed | -$317K | – | 591 |
|
|
2015
Q2 | $317K | Sell |
5,829
-167
| -3% | -$9.37K | 0.02% | 438 |
|
|
2015
Q1 | $329K | Buy |
+5,996
| New | +$340K | 0.02% | 415 |
|
|
2014
Q4 | – | Sell |
-6,649
| Closed | -$376K | – | 378 |
|
|
2014
Q3 | $376K | Buy |
6,649
+2,503
| +60% | +$141K | 0.04% | 213 |
|
|
2014
Q2 | $229K | Sell |
4,146
-14
| -0.3% | -$764 | 0.04% | 295 |
|
|
2014
Q1 | $225K | Buy |
+4,160
| New | +$215K | 0.05% | 237 |
|
Other funds holding MRK
VCM
VPM
Rafferty Asset Management's MRK Position: Q1 2026 in Review
Rafferty Asset Management reduced its Merck (MRK) stake by 28% in Q1 2026, selling an estimated $8.84M and leaving 193,053 shares worth $23.2M. The position accounts for 0.09% of the portfolio, ranked #115.
Rafferty Asset Management first reported a position in MRK in Q1 2014 and has held it in 36 quarters since. The position peaked at $35M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Rafferty Asset Management held 193,053 shares of Merck worth $23.2M as of Q1 2026.
- Rafferty Asset Management sold 76,567 Merck shares in Q1 2026, an estimated $8.84M.
- Merck made up 0.09% of Rafferty Asset Management's portfolio in Q1 2026, its #115 holding.
- Rafferty Asset Management first reported a position in Merck in Q1 2014 and has held it in 36 quarters since.
- Rafferty Asset Management's Merck position peaked at $35M in Q1 2024.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.